Bartlett & Co’s Novo Nordisk NVO Stock Holding History

Bartlett & Co’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$10.7M	Buy	103,881 +607	+0.6%	+$60K	0.17%	92
2023 Q3	$9.39M	Hold	103,274	–	–	0.17%	94
2023 Q2	$8.36M	Hold	103,274	–	–	0.14%	105
2023 Q1	$8.28M	Hold	103,274	–	–	0.16%	99
2022 Q4	$6.99M	Sell	103,274 -3,114	-3%	-$183K	0.14%	113
2022 Q3	$5.3M	Hold	106,388	–	–	0.11%	124
2022 Q2	$5.93M	Hold	106,388	–	–	0.12%	119
2022 Q1	$5.96M	Sell	106,388 -2,510	-2%	-$129K	0.1%	125
2021 Q4	$6.1M	Hold	108,898	–	–	0.1%	124
2021 Q3	$5.23M	Sell	108,898 -48	-0%	-$2.32K	0.1%	122
2021 Q2	$4.56M	Hold	108,946	–	–	0.09%	131
2021 Q1	$3.67M	Sell	108,946 -2,700	-2%	-$96.2K	0.07%	136
2020 Q4	$3.9M	Sell	111,646 -1,728	-2%	-$59.7K	0.08%	137
2020 Q3	$3.94M	Sell	113,374 -1,500	-1%	-$50K	0.09%	133
2020 Q2	$3.76M	Hold	114,874	–	–	0.1%	132
2020 Q1	$3.46M	Buy	+114,874	New	+$3.42M	0.11%	127
2019 Q3	$3.13M	Buy	121,054 +1,334	+1%	+$33.7K	0.08%	142
2019 Q2	$3.06M	Sell	119,720 -780	-0.6%	-$19.3K	0.11%	108
2019 Q1	$3.15M	Sell	120,500 -4,000	-3%	-$98.3K	0.12%	105
2018 Q4	$2.87M	Sell	124,500 -180	-0.1%	-$4K	0.12%	105
2018 Q3	$2.94M	Hold	124,680	–	–	0.11%	107
2018 Q2	$2.88M	Sell	124,680 -810	-0.6%	-$19.3K	0.12%	103
2018 Q1	$3.09M	Sell	125,490 -3,590	-3%	-$94.3K	0.13%	98
2017 Q4	$3.46M	Sell	129,080 -4,000	-3%	-$102K	0.14%	98
2017 Q3	$3.2M	Hold	133,080	–	–	0.13%	100
2017 Q2	$2.85M	Hold	133,080	–	–	0.13%	99
2017 Q1	$2.28M	Hold	133,080	–	–	0.1%	108
2016 Q4	$2.39M	Sell	133,080 -1,950	-1%	-$35.4K	0.11%	103
2016 Q3	$2.81M	Sell	135,030 -5,200	-4%	-$129K	0.14%	99
2016 Q2	$3.77M	Hold	140,230	–	–	0.19%	89
2016 Q1	$3.8M	Hold	140,230	–	–	0.19%	87
2015 Q4	$4.07M	Buy	140,230 +1,950	+1%	+$54K	0.21%	87
2015 Q3	$3.75M	Sell	138,280 -1,950	-1%	-$55.2K	0.21%	89
2015 Q2	$3.84M	Sell	140,230 -600	-0.4%	-$16.9K	0.19%	88
2015 Q1	$3.76M	Sell	140,830 -650	-0.5%	-$15K	0.19%	90
2014 Q4	$2.99M	Sell	141,480 -100	-0.1%	-$2.23K	0.14%	93
2014 Q3	$3.37M	Hold	141,580	–	–	0.16%	91
2014 Q2	$3.27M	Buy	141,580 +100	+0.1%	+$2.21K	0.16%	92
2014 Q1	$3.23M	Hold	141,480	–	–	0.16%	91
2013 Q4	$2.61M	Sell	141,480 -5,120	-3%	-$89.2K	0.13%	92
2013 Q3	$2.48M	Buy	146,600 +120	+0.1%	+$2.02K	0.13%	93
2013 Q2	$2.27M	Buy	+146,480	New	+$2.44M	0.13%	95

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Bartlett & Co's NVO Position: Q4 2023 in Review

Bartlett & Co increased its Novo Nordisk (NVO) stake by 0.59% in Q4 2023, buying an estimated $60K and bringing the position to 103,881 shares worth $10.7M. The position accounts for 0.17% of the portfolio, ranked #92.

Bartlett & Co first reported a position in NVO in Q2 2013 and has held it in 42 quarters since. 1,511 funds tracked by Wall St. Rank hold NVO as of Q4 2023.

Bartlett & Co held 103,881 shares of Novo Nordisk worth $10.7M as of Q4 2023.
Bartlett & Co bought 607 Novo Nordisk shares in Q4 2023, an estimated $60K.
Novo Nordisk made up 0.17% of Bartlett & Co's portfolio in Q4 2023, its #92 holding.
Bartlett & Co first reported a position in Novo Nordisk in Q2 2013 and has held it in 42 quarters since.
1,511 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.